Yüklüyor......
Bradycardia associated with pegylated liposomal doxorubicin administration: a case report
The cardiotoxicity of doxorubicin is dose dependent and progressive, but its mechanisms remain unclear. Measures to prevent the cardiotoxicity of doxorubicin have had limited success. We report here on a patient who had received intravenous infusion of pegylated liposomal doxorubicin and developed s...
Kaydedildi:
| Yayımlandı: | Eur J Hosp Pharm |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6451597/ https://ncbi.nlm.nih.gov/pubmed/31156919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2015-000817 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|